Drug Profile
Research programme: type 1 diabetes therapeutics - Peptimmune
Alternative Names: DEEP-CopQLatest Information Update: 29 Aug 2011
Price :
$50
*
At a glance
- Originator Peptimmune
- Class Polymers
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Suspended Type 1 diabetes mellitus
Most Recent Events
- 19 Jul 2010 Preclinical trials in Type-1 diabetes mellitus in USA (unspecified route)